Marianne Stapper

Title: The Innovative Contributions of Marianne Stapper

Introduction

Marianne Stapper is a notable inventor based in the Australian Capital Territory, Australia. She has made significant contributions to the field of biotechnology, particularly in the development of ribozymes. With a total of two patents to her name, her work has implications for both diagnostic and therapeutic applications.

Latest Patents

Marianne's latest patents include "Ribozymes with optimized hybridizing arms, stems, and loops, tRNA." This invention focuses on improved catalytic compounds, specifically hammerhead ribozymes, which are capable of hybridizing with target RNA for cleavage. The optimized compounds feature enhanced stems, loops, and hybridizing arms. Additionally, her invention encompasses compositions for enhanced RNA cleavage, which consist of synthetic non-naturally occurring oligonucleotide compounds. These compounds are designed to include a conserved catalytic region and sequences that can hybridize with predetermined target sequences. The ribozymes and compositions developed by Marianne can be utilized in both in vitro and in vivo settings, serving as valuable diagnostic or therapeutic agents.

Career Highlights

Marianne Stapper is associated with Gene Shears Pty. Limited, where she continues to advance her research and innovations. Her work has positioned her as a key figure in the biotechnology sector, contributing to the understanding and application of ribozymes in various scientific fields.

Collaborations

Some of Marianne's notable coworkers include Paul Keese and Rhonda Perriman. Their collaborative efforts have further enhanced the research and development of innovative solutions in biotechnology.

Conclusion

Marianne Stapper's contributions to the field of biotechnology through her patents and collaborative work highlight her role as an influential inventor. Her innovations in ribozymes have the potential to impact both diagnostic and therapeutic practices significantly.